Maestas Nicholas 4
4 · Tempest Therapeutics, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Maestas Nicholas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-21+51,270→ 51,270 totalExercise: $2.35Exp: 2032-06-20→ Common Stock (51,270 underlying)
Footnotes (1)
- [F1]Vests over four (4) years, with one-fourth (1/4) of the award vesting on the first anniversary of the date of grant and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.